Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Counsyl | RCV000412236 | SCV000485980 | likely pathogenic | Cohen syndrome | 2016-03-11 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000412236 | SCV000630878 | pathogenic | Cohen syndrome | 2022-02-18 | criteria provided, single submitter | clinical testing | For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 370619). This premature translational stop signal has been observed in individual(s) with Cohen syndrome (PMID: 20683995). This variant is present in population databases (no rsID available, gnomAD 0.006%). This sequence change creates a premature translational stop signal (p.Gln1864*) in the VPS13B gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in VPS13B are known to be pathogenic (PMID: 15141358, 16648375, 20461111). |
Gene |
RCV003325481 | SCV004031799 | pathogenic | not provided | 2023-08-28 | criteria provided, single submitter | clinical testing | Nonsense variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss of function is a known mechanism of disease; Not observed at significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 25525159, 20683995, 27457812) |